Literature DB >> 25941350

CARD9 Promotes Sex-Biased Colon Tumors in the APCmin Mouse Model.

Vonny I Leo1, Sze Huey Tan2, Hanna Bergmann3, Peh Yean Cheah4, Min Hoe Chew5, Kiat Hon Lim6, Jürgen Ruland3, Patrick T Reilly7.   

Abstract

Caspase recuitment domain-containing protein 9 (CARD9) functions in different inflammation pathways to elicit responses to microbial signals and is known to affect intestinal inflammation. Examining the APC(min) mouse model of intestinal tumorigenesis and using stringently controlled, sex- and age-matched pairs of CARD9-competent and CARD9-deficient mice, we have found that CARD9 has a restricted but strong effect on tumorigenesis in the large intestine. We have found that CARD9 reduces viability specifically in males and promotes tumorigenesis specifically in the large intestines of these male mice. To our knowledge, this is the first gene ablation in APC(min) mice that solely affects colon tumors in male subjects and, as such, may have significant clinical implications. Additional data suggest correlative disruption of plasma cytokine expression and immune infiltration of the tumors. We speculate that known sex-specific differences in human colorectal cancer may involve inflammation, particularly CARD9-dependent inflammation. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25941350     DOI: 10.1158/2326-6066.CIR-14-0148

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  9 in total

1.  Comparative Study of the Role of Interepithelial Mucosal Mast Cells in the Context of Intestinal Adenoma-Carcinoma Progression.

Authors:  Tanja Groll; Miguel Silva; Rim Sabrina Jahan Sarker; Markus Tschurtschenthaler; Theresa Schnalzger; Carolin Mogler; Daniela Denk; Sebastian Schölch; Barbara U Schraml; Jürgen Ruland; Roland Rad; Dieter Saur; Wilko Weichert; Moritz Jesinghaus; Kaspar Matiasek; Katja Steiger
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 2.  The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis.

Authors:  Muhan Li; Runfeng Zhang; Ji Li; Jingnan Li
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

3.  Fibersol-2 induces apoptosis of Apc-deficient colorectal Cancer (SW480) cells and decreases polyp formation in Apc MIN mice.

Authors:  Sara Cuesta Sancho; Susan Losee Olson; Eui Young So; Kazuhiro Shimomura; Toru Ouchi; Fabian Preuss
Journal:  Cancer Biol Ther       Date:  2016-05-04       Impact factor: 4.742

Review 4.  Molecular and physiological roles of the adaptor protein CARD9 in immunity.

Authors:  Xiaoming Zhong; Bin Chen; Liang Yang; Zhiwen Yang
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

5.  Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.

Authors:  Linyue Pan; Yuting Tan; Bin Wang; Wenjia Qiu; Yulei Yin; Haiyan Ge; Huili Zhu
Journal:  Cancer Res Treat       Date:  2020-03-11       Impact factor: 4.679

6.  Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma.

Authors:  Nobufumi Sekino; Masayuki Kano; Haruhito Sakata; Kentaro Murakami; Takeshi Toyozumi; Yasunori Matsumoto; Takahiro Ryuzaki; Junichiro Ikeda; Masayuki Ota; Hisahiro Matsubara
Journal:  Ann Gastroenterol Surg       Date:  2019-12-22

Review 7.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 8.  Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.

Authors:  Lilong Zhang; Dongqi Chai; Chen Chen; Chunlei Li; Zhendong Qiu; Tianrui Kuang; Mungur Parveena; Keshuai Dong; Jia Yu; Wenhong Deng; Weixing Wang
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

Review 9.  The Role of Adaptor Protein CARD9 in Colitis-Associated Cancer.

Authors:  Xiaoming Zhong; Bin Chen; Min Liu; Zhiwen Yang
Journal:  Mol Ther Oncolytics       Date:  2019-08-30       Impact factor: 7.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.